Need professional-grade analysis? Visit stockanalysis.com
$10.27B
N/A
N/A
N/A
Madrigal Pharmaceuticals Inc (MDGL) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $532.02, up 1.38% from the previous close.
Over the past year, MDGL has traded between a low of $267.56 and a high of $602.83. The stock has gained 75.7% over this period. It is currently 11.7% below its 52-week high.
Madrigal Pharmaceuticals Inc has a market capitalization of $10.27B.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Side-by-side comparison against top Healthcare peers.